Compare Motorola Solutions Inc (MSI) vs Oscar Health Inc (OSCR) Price & Performance

Motorola Solutions (MSI) trades at $462.98, down 1.08% on the day, amid a bullish technical setup with strong support at $459. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue growth is steady, reaching $11.68 billion in 2025, while net income margin improved to 17.44%. Recent news highlights a $2 billion share repurchase authorization and the completion of the $1.5 billion D-Fend Solutions acquisition, expanding its counter-drone portfolio.

The outlook remains positive given analyst consensus favoring Buy ratings (70.59%) and a price target of $536.50, implying ~16% upside. Key risks include elevated valuation multiples (P/E 36.48) and significant investing cash outflows ($-5.16 billion in 2025) from acquisitions. Execution on integration and debt management will be critical for sustaining shareholder value amid competitive pressures.

Oscar Health (OSCR) trades at $33.01, up 2.36% today and approaching its 52-week high of $33.10. The stock shows strong technical momentum with bullish moving averages and has surged 109% year-to-date. Fundamentally, revenue grew from $11.7B in 2025 to $15.3B in 2026, with net income turning positive at $551M. Recent earnings beats and membership growth to 2.96 million support the bullish case, though valuation metrics like P/E of 25.39 and P/B of 4.97 suggest premium pricing.

Outlook remains positive with strong revenue growth and profitability improvements, but risks include high valuation multiples and dependence on sustained membership growth. Analyst consensus is mixed with 27% buy ratings and a $30.67 price target below current levels, indicating caution despite technical strength. Key catalysts include continued operational efficiency gains and AI integration, while medical cost management remains critical.